SAN DIEGO – Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of B. Melina Cimler, Ph.D., as Vice President, Quality and Regulatory Affairs, reporting to Christian Henry, Senior Vice President, Chief Financial Officer and General Manager, Life Sciences. Dr. Cimler will lead Illumina’s quality and regulatory organizations to support the development, manufacture and distribution of products […]
Joint services offered for human exome targeted re-sequencing based on Roche NimbleGen format Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Certified Service Provider for Roche NimbleGen sequence capture, together with Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce that they have developed a […]
Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) announced today that Seoul-based genomic services provider Macrogen, Inc. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program. Macrogen has been certified to process customer samples for NimbleGen Comparative Genomic Hybridization/Copy Number Variation (CGH/CNV) services in their lab in Seoul. As a CSP, Macrogen will process […]
SAN DIEGO – Illumina, Inc. (NASDAQ:ILMN) today announced that Gerald Möller, Ph.D., has joined the company’s Board of Directors. Dr. Möller is currently an advisor at HBM Bio Ventures AG, a Swiss investment firm focusing on biotechnology, emerging pharma, medical technology and related industries. Previously, Dr. Möller spent 23 years at Boehringer Mannheim in Germany, […]
Hyderabad, Andhra Pradesh, India – Ocimum Biosolutions, a global integrated genomics company, today announced that it now offers cutting edge solutions using miRNA microarray technology. A wide range of miRNA microarray kits and assays including human, mouse, rat and other systems are available immediately on Ocimum’s proprietary OciChip™ platform. The epoxide coated microarray slides are […]
SAN DIEGO – Illumina, Inc. (NASDAQ:ILMN) today announced that it has appointed Nicholas J. Naclerio, Ph.D., to the position of senior vice president, Corporate Development, reporting to Jay Flatley, president and chief executive officer. In this capacity, Dr. Naclerio will be responsible for all Corporate and Business Development activities, including licensing, strategic planning and acquisitions. […]
Researchers can better determine risk while speeding the pace and increasing the accuracy of clinical phase research efforts Billerica, Mass. – Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis, has launched new Human multiplex biomarker panels for the quantification of eight biomarkers related to […]
SUNNYVALE, Calif. – Arrayit Corporation (OTCBB:ARYC – News), a leader in life sciences and healthcare technology, announced today that the company has received a registered trademark Notice of Allowance from the United States Patent and Trademark Office (USPTO) for the company’s OvaDx® pre-symptomatic ovarian cancer test. The June 29th, 2010 issuance of USPTO serial number […]
Scienion’s innovative dispensing technology is excellently suited for a variety of applications wherever contact-free precise handling of ultra low volume liquids is needed. For Prof. Peter H. Seeberger, Max Planck Institute of Colloids and Interfaces, the sciFLEYXARRAYER proved to be the best choice for the production of carbohydrate arrays. Dortmund and Berlin, Germany – Glycobiology […]
CSIRO Study Will Facilitate Deeper Understanding of Oceanic Microbial Ecology and Bioremediation SUNNYVALE, Calif. — — Arrayit Corporation (OTCBB: ARYC – News), a leader in life sciences and healthcare technology, reports today that the company has installed its patented and proprietary NanoPrint™ LM60 Enterprise Level Microarrayer at the Commonwealth Scientific and Industrial Research Organization (CSIRO) […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
